Frenzen P D
Economic Research Service, US Department of Agriculture, Washington, DC 20036-5831, USA.
Neuroepidemiology. 2007;29(1-2):83-8. doi: 10.1159/000109501.
The hospitalization rate for Guillain-Barré syndrome (GBS) in the USA has recently decreased. This study examined which demographic groups were affected and whether there were any changes in medical care that might explain the decrease.
Information about hospitalizations for GBS was obtained from the 1993-2004 annual Nationwide Inpatient Sample and used to estimate hospitalization rates and the medical characteristics of hospitalized GBS patients.
The GBS hospitalization rate decreased 20.1% (95% CI 18.3-21.9%) between 1993 and 2004. Most groups were affected by the decrease except persons aged 18-44 years. There were several changes in medical care during the period, including a reduction in interhospital transfers and a shift from plasmapheresis to intravenous immunoglobulin (IVIg) therapy.
The reduction in transfers accounted for about one-fourth of the decrease in the GBS hospitalization rate, and may have been related to the shift from plasmapheresis to IVIg therapy. The other causes of the decrease are unknown.
美国吉兰 - 巴雷综合征(GBS)的住院率最近有所下降。本研究调查了哪些人群受到影响,以及医疗护理方面是否有任何变化可以解释这种下降。
从1993 - 2004年全国住院患者样本中获取GBS住院信息,用于估计住院率以及住院GBS患者的医疗特征。
1993年至2004年间,GBS住院率下降了20.1%(95%可信区间18.3 - 21.9%)。除18 - 44岁人群外,大多数群体都受到了下降的影响。在此期间医疗护理有多项变化,包括医院间转诊减少以及从血浆置换疗法转向静脉注射免疫球蛋白(IVIg)疗法。
转诊减少约占GBS住院率下降的四分之一,可能与从血浆置换疗法转向IVIg疗法有关。下降的其他原因尚不清楚。